doi: 10.1038/s41598-025-92868-y 74 PereiraAGEchaveJJorgeAOSNogueira-MarquesRNur YuksekEBarcielaPet al
"However, the study cannot exclude a small increase in risk." One author disclosed ties to the biopharmaceutical industry
Bu ilac bir uzun yaam destekisi olarak kullanma konusunda da uzmanlar unu sylyor: Eer salklysak, glikoz ve inslin seviyelerimiz normalse, bbrek fonksiyonlarmzda herhangi bir problem yoksa GLP-1i sentetik bir biimde almamza da gerek yok
For moderate weight loss, metabolic tuning, inflammation, and even heart-protective benefits, lower doses may be enough for some people
Du hast Fragen zur Vertrglichkeit
[PMC free article] [PubMed] [Google Scholar] 71.Swift NC, Marks SL, MacLachlan NJ